JP2005306781A - ビフィズス菌増殖用オリゴ糖 - Google Patents
ビフィズス菌増殖用オリゴ糖 Download PDFInfo
- Publication number
- JP2005306781A JP2005306781A JP2004126086A JP2004126086A JP2005306781A JP 2005306781 A JP2005306781 A JP 2005306781A JP 2004126086 A JP2004126086 A JP 2004126086A JP 2004126086 A JP2004126086 A JP 2004126086A JP 2005306781 A JP2005306781 A JP 2005306781A
- Authority
- JP
- Japan
- Prior art keywords
- bifidobacteria
- oligosaccharide
- clostridium
- bacteria
- kestose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186000 Bifidobacterium Species 0.000 title claims abstract description 120
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 70
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 69
- 230000035755 proliferation Effects 0.000 title abstract description 4
- 241000193403 Clostridium Species 0.000 claims abstract description 74
- VAWYEUIPHLMNNF-OESPXIITSA-N 1-kestose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VAWYEUIPHLMNNF-OESPXIITSA-N 0.000 claims abstract description 46
- GIUOHBJZYJAZNP-DVZCMHTBSA-N 1-kestose Natural products OC[C@@H]1O[C@](CO)(OC[C@]2(O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)O[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O GIUOHBJZYJAZNP-DVZCMHTBSA-N 0.000 claims abstract description 46
- VAWYEUIPHLMNNF-UHFFFAOYSA-N kestotriose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OC2C(C(O)C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 VAWYEUIPHLMNNF-UHFFFAOYSA-N 0.000 claims abstract description 46
- 230000000968 intestinal effect Effects 0.000 claims abstract description 45
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 claims abstract description 36
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 claims abstract description 33
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 abstract description 27
- 239000000203 mixture Substances 0.000 abstract description 14
- 238000002474 experimental method Methods 0.000 description 35
- 210000003608 fece Anatomy 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 20
- 239000002609 medium Substances 0.000 description 15
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 13
- 229940107187 fructooligosaccharide Drugs 0.000 description 13
- 230000003247 decreasing effect Effects 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 7
- 230000002950 deficient Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 241001112695 Clostridiales Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QNTKVQQLMHZOKP-NEJDVEAASA-N (2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-2-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]- Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QNTKVQQLMHZOKP-NEJDVEAASA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241000193462 [Clostridium] innocuum Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- -1 trisaccharide oligosaccharide Chemical class 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Landscapes
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【解決手段】 オリゴ糖の組成をビフィズス菌に資化性のある1−ケストースを主成分とし、クロストリジウム属菌に資化性のあるニストースを極力含まない組成にすることにより、ビフィズス菌よりもクロストリジウム属菌等の有害菌が優勢な腸内環境下であってもクロストリジウム属菌数の増加を抑制し、ビフィズス菌を増殖させる。
【選択図】 図9
Description
まず、本発明の課題となる事実、すなわち、クロストリジウム属菌等の有害菌数がビフィズス菌数に対して優勢な腸内環境下においては、ある種のオリゴ糖によるビフィズス菌増殖機能が弱められるという事実について説明する。
つぎに、実験1の結果、腸内有害菌であるクロストリジウム属菌数が腸内有用菌であるビフィズス菌数よりも多い腸内環境下においては、フラクトオリゴ糖によるビフィズス菌増殖機能が低下するという事実の原因を究明する実験を行った。
以上の実験結果に基づき、本発明に係るビフィズス菌増殖用オリゴ糖の実施形態について図面を参照しつつ説明する。
Claims (8)
- 1−ケストースを主成分として有しており、クロストリジウム属菌数がビフィズス菌数よりも多い腸内環境下において前記ビフィズス菌を増殖させることを特徴とするビフィズス菌増殖用オリゴ糖。
- クロストリジウム属菌数がビフィズス菌数よりも多い腸内環境下において前記ビフィズス菌を増殖させる量の1−ケストースを含有していることを特徴とするビフィズス菌増殖用オリゴ糖。
- クロストリジウム属菌数がビフィズス菌数よりも多い腸内環境下において前記クロストリジウム属菌数を減少させるようにニストースの含有量を減少させていることを特徴とするビフィズス菌増殖用オリゴ糖。
- 請求項1において、前記1−ケストースの量がニストースよりも多く含有されていることを特徴とするビフィズス菌増殖用オリゴ糖。
- 請求項1において、前記1−ケストースの純度が90%以上であることを特徴とするビフィズス菌増殖用オリゴ糖。
- 請求項5において、前記1−ケストースは、純度が95%以上の結晶化されたケストースであることを特徴とするビフィズス菌増殖用オリゴ糖。
- 請求項3または請求項4において、前記ニストースは、純度が少なくとも4%以下にされていることを特徴とするビフィズス菌増殖用オリゴ糖。
- 請求項1乃至請求項7のいずれかにおいて、前記腸内環境は、クロストリジウム属菌数がビフィズス菌数より4倍以上の有害菌優勢腸内環境であることを特徴とするビフィズス菌増殖用オリゴ糖。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004126086A JP4669235B2 (ja) | 2004-04-21 | 2004-04-21 | 腸内環境下ビフィズス菌増殖剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004126086A JP4669235B2 (ja) | 2004-04-21 | 2004-04-21 | 腸内環境下ビフィズス菌増殖剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005306781A true JP2005306781A (ja) | 2005-11-04 |
JP4669235B2 JP4669235B2 (ja) | 2011-04-13 |
Family
ID=35435941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004126086A Expired - Lifetime JP4669235B2 (ja) | 2004-04-21 | 2004-04-21 | 腸内環境下ビフィズス菌増殖剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4669235B2 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007043563A1 (ja) * | 2005-10-13 | 2007-04-19 | Meiji Seika Kaisha, Ltd. | 腸内フローラ改善用組成物 |
EP1878738A1 (en) * | 2005-04-21 | 2008-01-16 | The Hokuren Federation Of Agricultural Cooperatives | Allergy-suppressive composition, allergy-suppressive food and allergy-suppressive agent |
WO2017159647A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | フィーカリバクテリウム属細菌増殖剤 |
WO2017159643A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | 腸内酪酸増加剤および酪酸産生菌増殖剤 |
WO2019054396A1 (ja) * | 2017-09-13 | 2019-03-21 | 物産フードサイエンス株式会社 | フソバクテリウム属細菌および/またはステレラ属細菌の菌数抑制剤 |
WO2022255441A1 (ja) * | 2021-06-03 | 2022-12-08 | 森永乳業株式会社 | 組成物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10175867A (ja) * | 1996-12-12 | 1998-06-30 | Morinaga Milk Ind Co Ltd | ビフィズス菌増殖促進組成物及びその用途 |
JP2003048901A (ja) * | 2001-08-09 | 2003-02-21 | Oji Paper Co Ltd | 長鎖キシロオリゴ糖組成物およびその製造方法 |
JP2003055231A (ja) * | 2001-08-09 | 2003-02-26 | Oji Paper Co Ltd | 経腸栄養剤 |
JP2003183303A (ja) * | 2001-12-20 | 2003-07-03 | Oji Paper Co Ltd | 酸性キシロオリゴ糖組成物及びその製造方法 |
-
2004
- 2004-04-21 JP JP2004126086A patent/JP4669235B2/ja not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10175867A (ja) * | 1996-12-12 | 1998-06-30 | Morinaga Milk Ind Co Ltd | ビフィズス菌増殖促進組成物及びその用途 |
JP2003048901A (ja) * | 2001-08-09 | 2003-02-21 | Oji Paper Co Ltd | 長鎖キシロオリゴ糖組成物およびその製造方法 |
JP2003055231A (ja) * | 2001-08-09 | 2003-02-26 | Oji Paper Co Ltd | 経腸栄養剤 |
JP2003183303A (ja) * | 2001-12-20 | 2003-07-03 | Oji Paper Co Ltd | 酸性キシロオリゴ糖組成物及びその製造方法 |
Non-Patent Citations (3)
Title |
---|
JPN6010052167, 食品と科学, 20040110, 46, 81−87 * |
JPN6010052168, 第102回精糖技術研究会講演要旨, 2004, 16−19 * |
JPN6010052170, 精糖技術研究会誌, 2004, 52, 13−18 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1878738A1 (en) * | 2005-04-21 | 2008-01-16 | The Hokuren Federation Of Agricultural Cooperatives | Allergy-suppressive composition, allergy-suppressive food and allergy-suppressive agent |
EP1878738B1 (en) * | 2005-04-21 | 2011-07-27 | The Hokuren Federation Of Agricultural Cooperatives | 1-kestose for treating allergy and atopic dermatitis |
WO2007043563A1 (ja) * | 2005-10-13 | 2007-04-19 | Meiji Seika Kaisha, Ltd. | 腸内フローラ改善用組成物 |
WO2017159647A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | フィーカリバクテリウム属細菌増殖剤 |
WO2017159643A1 (ja) * | 2016-03-14 | 2017-09-21 | 物産フードサイエンス株式会社 | 腸内酪酸増加剤および酪酸産生菌増殖剤 |
JP6275931B1 (ja) * | 2016-03-14 | 2018-02-07 | 物産フードサイエンス株式会社 | 腸内酪酸増加剤および酪酸産生菌増殖剤 |
JPWO2017159647A1 (ja) * | 2016-03-14 | 2018-03-22 | 物産フードサイエンス株式会社 | フィーカリバクテリウム属細菌増殖剤 |
WO2019054396A1 (ja) * | 2017-09-13 | 2019-03-21 | 物産フードサイエンス株式会社 | フソバクテリウム属細菌および/またはステレラ属細菌の菌数抑制剤 |
JPWO2019054396A1 (ja) * | 2017-09-13 | 2020-08-27 | 物産フードサイエンス株式会社 | フソバクテリウム属細菌および/またはステレラ属細菌の菌数抑制剤 |
JP7262391B2 (ja) | 2017-09-13 | 2023-04-21 | 物産フードサイエンス株式会社 | フソバクテリウム属細菌および/またはステレラ属細菌の菌数抑制剤 |
WO2022255441A1 (ja) * | 2021-06-03 | 2022-12-08 | 森永乳業株式会社 | 組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP4669235B2 (ja) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kolida et al. | Prebiotic effects of inulin and oligofructose | |
CA2497989C (en) | Probiotic bacterium: lactobacillus fermentum | |
DE60204662T2 (de) | Probiotika-kombination | |
EP0901371B1 (en) | Alteration of microbial populations in the gastrointestinal tract | |
AU2004228936B2 (en) | Synbiotic combination | |
Bosscher et al. | Inulin and oligofructose as prebiotics in the prevention of intestinal infections and diseases | |
CN101330838B (zh) | 预防剖腹产分娩的婴儿疾病的方法 | |
US20230149432A1 (en) | Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection | |
CN105283195A (zh) | 用于治疗过敏患者的感染的合生素组合物 | |
US20100322904A1 (en) | Composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants | |
TW201233334A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
CN1843385A (zh) | 肠道微生态制剂及其制备方法 | |
CN101043904A (zh) | 含有不可消化寡糖的营养组合物 | |
CA2774557A1 (en) | Lactobacillus plantarum strains as hypocholesterolemic agents | |
PT1255449E (pt) | Formulação nutricional contendo substâncias pré-bióticas | |
WO2009008717A1 (en) | Use of probiotics and fibers for diarrhoea | |
CN114504109B (zh) | 一种含乳双歧杆菌与母乳低聚糖的组合物及其应用 | |
CN105848499A (zh) | 含有不可消化寡糖的发酵配方物 | |
AU2019201637A1 (en) | Compositions Comprising a Mixture of Bacteria Comprising Pediococcus and Lactobacillus and Methods for Decreasing the Effects of Alcohols | |
CN114258961A (zh) | 乳双歧杆菌与母乳低聚糖组合物在婴幼儿配方食品中的应用 | |
CN109963569A (zh) | 用基于氨基酸的营养组合物喂养的婴儿或幼儿中肠道微生物群组成的正常化 | |
JP4669235B2 (ja) | 腸内環境下ビフィズス菌増殖剤 | |
JP2009084215A (ja) | 炎症性腸疾患予防・治療剤 | |
JP6301024B2 (ja) | フィーカリバクテリウム属細菌増殖剤 | |
Sharma et al. | Prebiotics: A review of therapeutic potential |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070419 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20090323 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100915 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20101006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101113 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101215 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110114 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140121 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4669235 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140121 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |